Welcome to our dedicated page for Nano-X Imaging Ltd. news (Ticker: NNOX), a resource for investors and traders seeking the latest updates and insights on Nano-X Imaging Ltd. stock.
Nanox Imaging Ltd (NASDAQ: NNOX) is transforming medical diagnostics through its digital X-ray systems and AI-powered imaging analytics. This news hub provides investors and healthcare professionals with essential updates about the company's technological advancements, regulatory milestones, and market developments.
Access real-time information on product launches, financial results, clinical partnerships, and technology patents. Our curated collection includes official press releases about the Nanox.ARC imaging system updates, Nanox.AI algorithm enhancements, and global deployment of cloud-based diagnostic solutions.
Stay informed about developments in medical imaging innovation while tracking the company's progress in making preventive care more accessible through cost-effective solutions. Bookmark this page for verified updates about FDA clearances, research collaborations, and operational expansions that shape the future of diagnostic technology.
Nano-X Imaging Ltd (Nasdaq: NNOX) has announced a strategic partnership with Ferrum Health to enhance its AI technologies for medical imaging. This collaboration aims to integrate Nanox.AI’s solutions, including the HealthOST and HealthCCSng applications, into Ferrum Health's platform. The partnership focuses on improving the adoption of AI in healthcare, providing advanced analytics for chronic disease detection, and enhancing patient outcomes. Ferrum's platform has already analyzed over 750,000 patient records, further solidifying their position in the AI healthcare space. Both companies aim to democratize access to innovative clinical AI technologies globally.
NANO-X IMAGING LTD (NASDAQ: NNOX) reported its fourth quarter 2022 results, concluding the year with $8.6 million in total revenue. The company generated $2.1 million in Q4, a slight decrease from $2.4 million in Q3. A significant net loss of $44.8 million was noted, largely due to a $36.5 million goodwill impairment. Cash and marketable securities stood at $102.9 million as of December 31, 2022. Key developments included the deployment of a Nanox.ARC system in Ghana and plans for a system in Nigeria, alongside a partnership with Nuance Precision Imaging Network to expand AI solutions. The conference call is scheduled for March 9, 2023.
FAQ
What is the current stock price of Nano-X Imaging Ltd. (NNOX)?
What is the market cap of Nano-X Imaging Ltd. (NNOX)?
